Skip to content
healthcare.dev

Raloxifene Hydrochloride

NDC 69097-825, Raloxifene, tablet, from Cipla USA Inc..

Product NDC
69097-825
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090842
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RALOXIFENE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
69097-825-026909708250230 TABLET in 1 BOTTLE (69097-825-02)
69097-825-0769097082507100 TABLET in 1 BOTTLE (69097-825-07)
69097-825-15690970825151000 TABLET in 1 BOTTLE (69097-825-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8fef5bfd-a786-4442-b09b-f3b81812cdac
  • NADAC price for package 69097082502

    GET /v1/drugs/nadac/69097082502
  • NADAC price for package 69097082507

    GET /v1/drugs/nadac/69097082507
  • NADAC price for package 69097082515

    GET /v1/drugs/nadac/69097082515

Use it

Look up 69097-825 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.